Analysts have been eager to weigh in on the Financial sector with new ratings on S&P Global (SPGI – Research Report), Victory Capital ...

Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform rating on the shares.

Check the time stamp on this data. Updated AI-Generated Signals for Viatris Inc. (VTRS) available here: VTRS. Type a few ...

Davis Selected Advisers' 13F portfolio saw changes with stake increases in tech and travel, while reducing in financial and ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Viatris Inc. (VTRS) is a global healthcare company formed through the merger of Mylan and Upjohn (a division of Pfizer) in ...

Healthcare’s resilience makes it a go-to sector during market volatility. With steady demand, innovation, and aging demographics driving growth, investors could consider investing in fundamentally ...

That’s because it’s gradually dawning on investors that they no longer can count on lower interest rates and inflation to support higher stock and bond prices. They are realizing that ...

A price to sales ("P/S") ratio of <1x is ... Analyst’s Disclosure: I/we have a beneficial long position in the shares of VTRS either through stock ownership, options, or other derivatives.